|

Physician's Choice Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since June 2026

Pipeline

Phase 2: 1

Top Sponsors

  • Sarcoma Alliance for Research through Collaboration1

Indications

  • Clear Cell Sarcoma (CCS)1
  • HLA-A*0201 Positive Cells Present1
  • Cancer1

Los Angeles, California1 trial

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

University of Southern California - Norris Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.